trial · primary record
Becotatug Vedotin
Nasopharyngeal Cancinoma (NPC)
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 298 |
| Primary completion | 2033-12 |
| Primary endpoint | Post-induction Therapy Complete Response Rate (post-IT CRR) |
| Registry ID | NCT07524413 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:39.120Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07524413
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.